Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuitive Surgical
ISRG
|
+$828M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$788M |
| 3 |
Qualcomm
QCOM
|
+$771M |
| 4 |
Apple
AAPL
|
+$719M |
| 5 |
Baxter International
BAX
|
+$571M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.57B |
| 2 |
Wells Fargo
WFC
|
+$967M |
| 3 |
KKR & Co
KKR
|
+$455M |
| 4 |
Booking.com
BKNG
|
+$401M |
| 5 |
GGP
GGP Inc.
GGP
|
+$384M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.16% |
| 2 | Healthcare | 9.53% |
| 3 | Financials | 9.25% |
| 4 | Consumer Discretionary | 7.98% |
| 5 | Communication Services | 7.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NINE
4451
DELISTED
Nine Energy Service
NINE
| $985K | ﹤0.01% |
32,227
+9,253
| +40% | +$281K |
|
4452
Capital City Bank Group
CCBG
$890M
| $984K | ﹤0.01% |
42,138
+1,770
| +4% | +$43.2K |
|
4453
Nuveen ESG Small-Cap ETF
NUSC
$1.33B
| $984K | ﹤0.01% |
31,156
+28,955
| +1,316% | +$916K |
|
4454
Vertiv
VRT
$105B
| $981K | ﹤0.01% |
+100,660
| New | +$988K |
|
|
SRGA
4455
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $981K | ﹤0.01% |
7,258
-990
| -12% | -$136K |
|
4456
EyePoint Inc
EYPT
$1.2B
| $979K | ﹤0.01% |
27,433
-350
| -1% | -$8.03K |
|
|
XRN
4457
Chiron Real Estate Inc
XRN
$477M
| $977K | ﹤0.01% |
20,705
+4,879
| +31% | +$221K |
|
4458
Lantheus
LNTH
$6.59B
| $977K | ﹤0.01% |
65,385
-26,781
| -29% | -$391K |
|
|
VLRS
4459
Controladora Vuela Compania de Aviacion
VLRS
$939M
| $974K | ﹤0.01% |
130,609
+3,698
| +3% | +$26.4K |
|
|
AKAO
4460
DELISTED
Achaogen Inc
AKAO
| $974K | ﹤0.01% |
244,309
+54,006
| +28% | +$326K |
|
4461
Enphase Energy
ENPH
$5.53B
| $973K | ﹤0.01% |
200,646
-38,522
| -16% | -$211K |
|
4462
Northrim BanCorp
NRIM
$587M
| $971K | ﹤0.01% |
93,536
+10,792
| +13% | +$114K |
|
|
PZC
4463
DELISTED
PIMCO California Municipal Income Fund III
PZC
| $969K | ﹤0.01% |
95,390
-4,334
| -4% | -$45.9K |
|
|
DS
4464
DELISTED
Drive Shack Inc.
DS
| $969K | ﹤0.01% |
162,567
-47,881
| -23% | -$303K |
|
4465
iRadimed
IRMD
$1.18B
| $967K | ﹤0.01% |
26,027
+595
| +2% | +$16.1K |
|
|
NETI
4466
DELISTED
Eneti Inc.
NETI
| $966K | ﹤0.01% |
14,348
+605
| +4% | +$39.4K |
|
|
ADMS
4467
DELISTED
Adamas Pharmaceuticals
ADMS
| $965K | ﹤0.01% |
48,188
-23,097
| -32% | -$542K |
|
|
REIS
4468
DELISTED
Reis, Inc.
REIS
| $965K | ﹤0.01% |
41,938
+21,456
| +105% | +$461K |
|
4469
Kura Oncology
KURA
$850M
| $963K | ﹤0.01% |
55,014
-25,197
| -31% | -$483K |
|
|
REVG
4470
DELISTED
REV Group
REVG
| $962K | ﹤0.01% |
61,235
-15,222
| -20% | -$249K |
|
|
AGEN
4471
Agenus
AGEN
$290M
| $957K | ﹤0.01% |
22,789
-8,712
| -28% | -$343K |
|
|
LMRK
4472
DELISTED
Landmark Infrastructure Partners LP Common Units
LMRK
| $953K | ﹤0.01% |
68,858
+7,659
| +13% | +$103K |
|
|
JKS
4473
JinkoSolar
JKS
$891M
| $952K | ﹤0.01% |
88,386
+27,644
| +46% | +$367K |
|
4474
Lexicon Pharmaceuticals
LXRX
$1.1B
| $950K | ﹤0.01% |
88,965
-58,240
| -40% | -$667K |
|
4475
Adicet Bio
ACET
$74.7M
| $948K | ﹤0.01% |
559
-226
| -29% | -$295K |
|
Similar funds
Morgan Stanley's Q3 2018 Portfolio in Review
As of Q3 2018, Morgan Stanley held 7,051 positions worth $400B, up 7.9% from $370B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Morgan Stanley's Q3 2018 filing shows 207 new, 2,867 increased, 3,206 reduced and 165 closed positions. Its largest new stake was Elanco Animal Health: 9,012,591 shares worth $314M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.57B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.
- Morgan Stanley's largest Q3 2018 buy was Elanco Animal Health: 9,012,591 shares worth $314M.
- Morgan Stanley added most to Intuitive Surgical in Q3 2018, an estimated $828M increase.
- Morgan Stanley's biggest Q3 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.57B.
- Morgan Stanley fully exited GGP Inc. in Q3 2018, selling an estimated $384M.
- Morgan Stanley's ten largest holdings make up 15% of its $400B portfolio in Q3 2018.
- Morgan Stanley opened 207 new positions and closed 165 in Q3 2018.
- Morgan Stanley's portfolio value rose 7.9% quarter-over-quarter to $400B.
Based on Morgan Stanley's 13F filing for Q3 2018, filed 14 Nov 2018.